← All Zhengye Biotechnology Holding LTD filings

Zhengye Biotechnology Holding LTD Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
ZYBT
Zhengye Biotechnology Holding LTD
SCHEDULE 13G: Zhengye Biotechnology Reports Over 90% Beneficial Ownership by Key Shareholder Group
A recent SEC Schedule 13G filing reveals that a group of entities, primarily controlled by Zhenfa Han, collectively hold 90.66% of Zhengye Biotechnology Holding Ltd.'s ordinary shares.